(Q40705838)

22 September 2017

title

Epstein-Barr virus antagonizes the antiproliferative activity of transforming growth factor-beta but does not abolish its signaling (English)

1 reference

22 September 2017

1 reference

Guido Bommer

3

0 references

author name string

Manuela Horndasch

1

1 reference

22 September 2017

Eva E Raschke

2

1 reference

22 September 2017

Marino Schuhmacher

4

1 reference

22 September 2017

Elisabeth Dumont

5

1 reference

22 September 2017

Conny Kuklik-Roos

6

1 reference

22 September 2017

Dirk Eick

7

1 reference

22 September 2017

Bettina Kempkes

8

1 reference

22 September 2017

language of work or name

English

0 references

publication date

1 October 2002

1 reference

International Journal of Cancer

22 September 2017

published in

1 reference

22 September 2017

volume

101

1 reference

22 September 2017

issue

5

1 reference

22 September 2017

page(s)

442-447

1 reference

Transcriptional control by the TGF-beta/Smad signaling system

22 September 2017

cites work

1 reference

TGFbeta signaling in growth control, cancer, and heritable disorders

21 January 2018

1 reference

Correlation between the growth-inhibitory effect of TGF-beta 1 and phenotypic characteristics in a panel of B-cell lines

21 January 2018

1 reference

Apoptosis induced by TGF-beta 1 in Burkitt's lymphoma cells is caspase 8 dependent but is death receptor independent.

21 January 2018

1 reference

Resistance to TGF-beta1 correlates with a reduction of TGF-beta type II receptor expression in Burkitt's lymphoma and Epstein-Barr virus-transformed B lymphoblastoid cell lines

21 January 2018

1 reference

Control of cell growth by c-Myc in the absence of cell division

21 January 2018

1 reference

Cell cycle activation by c-myc in a burkitt lymphoma model cell line.

21 January 2018

1 reference

Antagonistic effects of c-myc and Epstein-Barr virus latent genes on the phenotype of human B cells

21 January 2018

1 reference

Role of caspases and possible involvement of retinoblastoma protein during TGFbeta-mediated apoptosis of human B lymphocytes

21 January 2018

1 reference

Transforming growth factor beta 1 suppression of c-myc gene transcription: role in inhibition of keratinocyte proliferation

21 January 2018

1 reference

Identification and functional characterization of a Smad binding element (SBE) in the JunB promoter that acts as a transforming growth factor-beta, activin, and bone morphogenetic protein-inducible enhancer

21 January 2018

1 reference

Id3 inhibits B lymphocyte progenitor growth and survival in response to TGF-beta

21 January 2018

1 reference

Overexpression of the c-Myc oncoprotein blocks the growth-inhibitory response but is required for the mitogenic effects of transforming growth factor beta 1.

21 January 2018

1 reference

Myc downregulation by transforming growth factor beta required for activation of the p15(Ink4b) G(1) arrest pathway.

21 January 2018

1 reference

Activators of the Epstein-Barr virus lytic program concomitantly induce apoptosis, but lytic gene expression protects from cell death

21 January 2018

1 reference

Transforming growth factor beta 1 stimulates expression of the Epstein-Barr virus BZLF1 immediate-early gene product ZEBRA by an indirect mechanism which requires the MAPK kinase pathway

21 January 2018

1 reference

Antisense to the Epstein-Barr virus (EBV)-encoded latent membrane protein 1 (LMP-1) sensitizes EBV-immortalized B cells to transforming growth factor-beta and chemotherapeutic agents

21 January 2018

1 reference

Direct induction of cyclin D2 by Myc contributes to cell cycle progression and sequestration of p27.

21 January 2018

1 reference

Direct and indirect regulation of cytokine and cell cycle proteins by EBNA-2 during Epstein-Barr virus infection

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/IJC.10626

1 reference

22 September 2017

1 reference